Abstract: Disclosed is a method for operating an ultrasound diagnostic apparatus, comprising the steps of: acquiring a first ultrasound image of an object; detecting a first nerve region corresponding to a first target nerve in the first ultrasound image; determining whether an abnormal region is present in the first nerve region of the first ultrasound image, on the basis of a determination standard for determining whether a target nerve is abnormal; and on the basis of a result of determining whether an abnormal region is present in the first nerve region, displaying at least one of information on the abnormal region and basis information regarding the basis for determining the abnormal region as abnormal.

Abstract: An ultrasonic imaging apparatus and an ultrasonic image display method are disclosed. An ultrasonic imaging apparatus according to one disclosed embodiment can comprise: a display unit; a user interface; a memory for storing one or more instructions; and a processor for executing the one or more instructions so as to determine a reference point in an ultrasonic image, identify at least one anatomical structure of interest on the basis of a location relationship with the reference point with respect to the determined reference point, and control the display unit so that the identified anatomical structure of interest and information about the anatomical structure of interest are displayed.

Abstract: Disclosed is a method for operating an ultrasound diagnostic apparatus, comprising the steps of: acquiring a first ultrasound image of an object; detecting a first nerve region corresponding to a first target nerve in the first ultrasound image; determining whether an abnormal region is present in the first nerve region of the first ultrasound image, on the basis of a determination standard for determining whether a target nerve is abnormal; and on the basis of a result of determining whether an abnormal region is present in the first nerve region, displaying at least one of information on the abnormal region and basis information regarding the basis for determining the abnormal region as abnormal.

Abstract: An ultrasonic imaging apparatus and an ultrasonic image display method are disclosed. An ultrasonic imaging apparatus according to one disclosed embodiment can comprise: a display unit; a user interface; a memory for storing one or more instructions; and a processor for executing the one or more instructions so as to determine a reference point in an ultrasonic image, identify at least one anatomical structure of interest on the basis of a location relationship with the reference point with respect to the determined reference point, and control the display unit so that the identified anatomical structure of interest and information about the anatomical structure of interest are displayed.

Abstract: The described invention provides a topical bioadhesive film-forming pharmaceutical composition formulated for application directly to skin or to a substrate. The composition includes a therapeutic amount of an active agent; and one or more excipients selected from the group consisting of a non-cellulosic polymer or copolymer, a film forming agent, a plasticizer, a permeation enhancer, an antioxidant, a preservative, a solubilizer, a phase transfer catalyst, a viscosity modifier, a vitamin, a mineral nutrient, a solvent, a colorant and a fragrance. It further provides a delivery system comprising the composition and a means for administering the composition. It also describes uses of the delivery system in the manufacture of a medicament for treating a skin condition, disease or disorder, and a method for treating a skin condition, disease or disorder with the composition. The composition is characterized by: controlled release.

Abstract: The described invention provides a topical bioadhesive film-forming pharmaceutical composition formulated for application directly to skin or to a substrate. The composition includes a therapeutic amount of an active agent; and one or more excipients selected from the group consisting of a non-cellulosic polymer or copolymer, a film forming agent, a plasticizer, a permeation enhancer, an antioxidant, a preservative, a solubilizer, a phase transfer catalyst, a viscosity modifier, a vitamin, a mineral nutrient, a solvent, a colorant and a fragrance. It further provides a delivery system comprising the composition and a means for administering the composition. It also describes uses of the delivery system in the manufacture of a medicament for treating a skin condition, disease or disorder, and a method for treating a skin condition, disease or disorder with the composition. The composition is characterized by: controlled release.

Abstract: The described invention provides a topical bioadhesive film-forming pharmaceutical composition formulated for application directly to skin or to a substrate. The composition includes a therapeutic amount of an active agent; and one or more excipients selected from the group consisting of a non-cellulosic polymer or copolymer, a film forming agent, a plasticizer, a permeation enhancer, an antioxidant, a preservative, a solubilizer, a phase transfer catalyst, a viscosity modifier, a vitamin, a mineral nutrient, a solvent, a colorant and a fragrance. It further provides a delivery system comprising the composition and a means for administering the composition. It also describes uses of the delivery system in the manufacture of a medicament for treating a skin condition, disease or disorder, and a method for treating a skin condition, disease or disorder with the composition. The composition is characterized by: controlled release.

Abstract: The described invention provides a topical bioadhesive film-forming pharmaceutical composition formulated for application directly to skin or to a substrate. The composition includes a therapeutic amount of an active agent; and one or more excipients selected from the group consisting of a non-cellulosic polymer or copolymer, a film forming agent, a plasticizer, a permeation enhancer, an antioxidant, a preservative, a solubilizer, a phase transfer catalyst, a viscosity modifier, a vitamin, a mineral nutrient, a solvent, a colorant and a fragrance. It further provides a delivery system comprising the composition and a means for administering the composition. It also describes uses of the delivery system in the manufacture of a medicament for treating a skin condition, disease or disorder, and a method for treating a skin condition, disease or disorder with the composition. The composition is characterized by: controlled release.